Search
WNT-974
go.drugbank.com/drugs/DB12561InvestigationalWNT974 has been used in trials studying the treatment of Metastatic Colorectal Cancer and Squamous Cell Carcinoma, Head And Neck.
Emapunil
go.drugbank.com/drugs/DB12666InvestigationalEmapunil has been used in trials studying the basic science and diagnostic of Baseline, Blocking Receptor Binding, and Neurodegenerative Disorders.
PF-07799933
go.drugbank.com/drugs/DB17489InvestigationalPF-07799933 is a BRAF class 2 inhibitor developed by Pfizer.
Vurolenatide
go.drugbank.com/drugs/DB18440InvestigationalVurolenatide is a recombinant fusion protein comprising exenatide and XTEN.
Ingenol disoxate
go.drugbank.com/drugs/DB15109Investigationaland Extremities in Subjects With Actinic Keratosis). … Ingenol disoxate is under investigation in clinical trial NCT02120456 (Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk
VSF-173
go.drugbank.com/drugs/DB05753InvestigationalVSF-173 is an oral small molecule. It is an oral compound that has demonstrated effects on animal sleep/wake patterns and gene expression patterns suggestive of a stimulant effect.
Sonpiretigene isteparvovec
go.drugbank.com/drugs/DB17844InvestigationalSonpiretigene isteparvovec is an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic therapy. … Developed by Nanoscope Therapeutics, it is being investigated for vision restoration in advanced retinitis pigmentosa (RP).
Motexafin lutetium
go.drugbank.com/drugs/DB05296InvestigationalMotexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate ...
ISIS 104838
go.drugbank.com/drugs/DB16201InvestigationalISIS 104838 is under investigation in clinical trial NCT00048321 (ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis).
Categories: Nucleic Acids, Nucleotides, and NucleosidesISB 1342
go.drugbank.com/drugs/DB17251InvestigationalISB 1342 is a bispecific antibody simultaneously targeting CD38 and CD3.